Revivegen Co., Ltd. (TPEX:7578)
Taiwan
· Delayed Price · Currency is TWD 28.90
-1.20 (-3.99%)
Mar 9, 2026, 1:29 PM CST
Revivegen Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 444.4 | 447.86 | 393.59 | 339.16 | 337 | 196.41 |
| Revenue Growth (YoY) | 1.53% | 13.79% | 16.05% | 0.64% | 71.58% | - |
| Cost of Revenue | 341.32 | 333.73 | 282.94 | 223.14 | 241.52 | 133.84 |
| Gross Profit | 103.08 | 114.13 | 110.65 | 116.03 | 95.48 | 62.57 |
| Selling, General & Admin | 62.48 | 70.07 | 75.33 | 65.76 | 45.97 | 44.36 |
| Research & Development | 6.99 | 7.51 | 4.79 | 4.33 | 2.88 | 1.45 |
| Operating Expenses | 69.47 | 77.58 | 80.12 | 70.09 | 48.85 | 45.81 |
| Operating Income | 33.61 | 36.55 | 30.53 | 45.94 | 46.64 | 16.76 |
| Interest Expense | -31.94 | -35.55 | -5.82 | -5.42 | -3.65 | -3.97 |
| Interest & Investment Income | 18.04 | 26.7 | 18.55 | 1.22 | 0.05 | 0.09 |
| Earnings From Equity Investments | - | - | 0.44 | - | - | -0.21 |
| Currency Exchange Gain (Loss) | 7.94 | 32.57 | 2.68 | -2.22 | - | - |
| Other Non Operating Income (Expenses) | -4.79 | -0.7 | 0.55 | 1.49 | 2.36 | 1.64 |
| EBT Excluding Unusual Items | 22.85 | 59.58 | 46.93 | 41.01 | 45.4 | 14.32 |
| Gain (Loss) on Sale of Investments | - | - | 0.88 | - | 0.01 | - |
| Gain (Loss) on Sale of Assets | -11.81 | -6.09 | -0.5 | -2.77 | - | - |
| Pretax Income | 18.18 | 53.48 | 47.31 | 38.24 | 45.41 | 14.32 |
| Income Tax Expense | 2.63 | 7.81 | 11.32 | 12.47 | 9.99 | 3.04 |
| Earnings From Continuing Operations | 15.55 | 45.68 | 35.99 | 25.77 | 35.42 | 11.28 |
| Minority Interest in Earnings | -2.37 | -7.18 | 4.82 | 9.38 | 0.15 | - |
| Net Income | 13.18 | 38.5 | 40.81 | 35.15 | 35.57 | 11.28 |
| Net Income to Common | 13.18 | 38.5 | 40.81 | 35.15 | 35.57 | 11.28 |
| Net Income Growth | -73.93% | -5.67% | 16.12% | -1.20% | 215.49% | - |
| Shares Outstanding (Basic) | 56 | 54 | 43 | 30 | 26 | 24 |
| Shares Outstanding (Diluted) | 59 | 60 | 49 | 37 | 26 | 24 |
| Shares Change (YoY) | 4.17% | 23.26% | 33.56% | 38.70% | 11.24% | - |
| EPS (Basic) | 0.24 | 0.72 | 0.96 | 1.19 | 1.39 | 0.48 |
| EPS (Diluted) | 0.23 | 0.64 | 0.84 | 0.96 | 1.35 | 0.47 |
| EPS Growth | -74.69% | -23.81% | -12.94% | -28.57% | 185.18% | - |
| Free Cash Flow | -1,050 | -1,023 | -1,155 | -557.8 | -8.89 | -137.76 |
| Free Cash Flow Per Share | -17.80 | -16.98 | -23.63 | -15.25 | -0.34 | -5.81 |
| Dividend Per Share | 0.499 | 0.499 | 0.175 | 0.877 | 0.877 | - |
| Dividend Growth | 184.53% | 184.53% | -80.01% | - | - | - |
| Gross Margin | 23.20% | 25.48% | 28.11% | 34.21% | 28.33% | 31.86% |
| Operating Margin | 7.56% | 8.16% | 7.76% | 13.54% | 13.84% | 8.53% |
| Profit Margin | 2.97% | 8.60% | 10.37% | 10.36% | 10.55% | 5.74% |
| Free Cash Flow Margin | -236.38% | -228.35% | -293.38% | -164.46% | -2.64% | -70.14% |
| EBITDA | 120.24 | 114.91 | 100.13 | 118.69 | 102.83 | 50.86 |
| EBITDA Margin | 27.06% | 25.66% | 25.44% | 35.00% | 30.51% | 25.90% |
| D&A For EBITDA | 86.62 | 78.35 | 69.6 | 72.75 | 56.19 | 34.1 |
| EBIT | 33.61 | 36.55 | 30.53 | 45.94 | 46.64 | 16.76 |
| EBIT Margin | 7.56% | 8.16% | 7.76% | 13.54% | 13.84% | 8.53% |
| Effective Tax Rate | 14.49% | 14.59% | 23.92% | 32.61% | 22.00% | 21.25% |
Source: S&P Capital IQ. Standard template. Financial Sources.